proline has been researched along with losartan potassium in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Algermissen, B; Hampl, H; Nündel, M; Riedel, E; Scigalla, P; Stabell, U | 1 |
| Ikenaga, H; Suzuki, M; Takeuchi, M; Yoshida, A | 1 |
| Ahn, YS; Kim, CH; Kim, DG; Kim, HS; Kim, I; Lee, J; Seo, GH | 1 |
| Cabrera, R; Draganov, PV; Limaye, AR | 1 |
| Fan, B; Gu, X; Li, T; Xiao, Z; Yang, J | 1 |
| Brailsford, JA; Danishefsky, SJ; Dong, S; Shang, S; Tan, Z; Townsend, SD | 1 |
| Afdhal, NH; Albrecht, JK; Brass, CA; Bronowicki, JP; Burroughs, MH; Harrison, SA; Jacobson, IM; Koury, KJ; Manns, MP; Pedicone, LD; Poordad, F; Rajender Reddy, K; Sings, HL; Sniukiene, V; Sulkowski, MS | 1 |
| Heil, EL; Hynicka, LM | 1 |
| Afdhal, NH; Albrecht, JK; Alves, K; Bacon, BR; Balart, L; Brass, CA; Brown, RS; Burroughs, MH; Calleja, JL; Craxi, A; Deng, W; Dutko, FJ; Flamm, SL; Hézode, C; Koury, KJ; Kowdley, KV; Lawitz, E; Lee, SS; Morgan, TR; Nelson, DR; Nyberg, L; Pedicone, LD; Poordad, F; Reddy, KR; Rossaro, L; Sulkowski, MS; Wahl, J; Wedemeyer, H; Zeuzem, S | 1 |
| Pol, S | 1 |
1 review(s) available for proline and losartan potassium
| Article | Year |
|---|---|
Anemia management in patients with chronic viral hepatitis C.
Topics: Anemia; Antiviral Agents; Drug Monitoring; Drug Therapy, Combination; Erythropoietin; Hematinics; Hepacivirus; Hepatitis C, Chronic; Humans; Oligopeptides; Proline; Ribavirin; Risk Factors; Serine Proteinase Inhibitors; Viral Nonstructural Proteins | 2013 |
2 trial(s) available for proline and losartan potassium
| Article | Year |
|---|---|
Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial.
Topics: Adult; Anemia; Antiviral Agents; Drug Therapy, Combination; Erythropoietin; Female; Hematinics; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Placebos; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Treatment Outcome | 2013 |
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.
Topics: Algorithms; Anemia; Antiviral Agents; Disease Management; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythropoietin; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Treatment Outcome | 2013 |
7 other study(ies) available for proline and losartan potassium
| Article | Year |
|---|---|
Changes in the concentrations of hydroxyproline, glycine and serine in the plasma of haemodialysis patients undergoing erythropoietin therapy.
Topics: Adult; Aged; Anemia; Erythropoietin; Female; Follow-Up Studies; Glycine; Hemoglobins; Humans; Hydroxyproline; Male; Middle Aged; Parathyroid Hormone; Proline; Recombinant Proteins; Renal Dialysis; Serine | 1989 |
Discovery of the shortest sequence motif for high level mucin-type O-glycosylation.
Topics: Acetylgalactosamine; Amino Acid Sequence; Animals; Binding Sites; Cattle; Colostrum; Erythropoietin; Glycosylation; Humans; Kinetics; Molecular Sequence Data; Mucins; Peptide Fragments; Peptide Mapping; Proline | 1997 |
Inhibitory effect of zinc on hypoxic HIF-1 activation in astrocytes.
Topics: Antineoplastic Agents; Astrocytoma; Cell Line, Tumor; Cell Nucleus; Dose-Response Relationship, Drug; Drug Interactions; Electrophoretic Mobility Shift Assay; Erythropoietin; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Proline; Protein Transport; Thiocarbamates; Time Factors; Zinc Sulfate | 2008 |
Boceprevir for chronic HCV genotype 1 infection.
Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Erythropoietin; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Viral Load | 2011 |
Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis.
Topics: Adolescent; Adult; Angiogenesis Inducing Agents; Animals; Chick Embryo; Chorioallantoic Membrane; Erythropoietin; Female; Humans; Male; Mice; Mice, Nude; Middle Aged; Neovascularization, Pathologic; Pituitary Neoplasms; Proline; Rats; Receptors, Erythropoietin; Xenograft Model Antitumor Assays; Young Adult | 2012 |
Advances in proline ligation.
Topics: Erythropoietin; Molecular Structure; Proline; Stereoisomerism | 2012 |
HCV, ribavirin, and anemia: a new dawn.
Topics: Anemia; Erythropoietin; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin | 2013 |